Neumora Therapeutics, Inc. (NMRA)

Profile

Full Name

Neumora Therapeutics, Inc.

Ticker

NASDAQ: NMRA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

September 15, 2023

Indexes

Not included

Website

https://www.neumoratx.com

Employees

103

Key Details

Price

$2.24(-2.18%)

Market Cap

$374.28M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-$1.53(-2.98% YoY)

PE Ratio

-

Next earnings date

Mar 2, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.24
    NMRA price is $2.24

    30-Day Relative Volume

    0.16
    NMRA 30-day relative volume is 0.16

    Price Performance

    Price Most Recent Change

    -2.18%
    NMRA price was down -2.18% on Nov 28, 2025

    Price YTD Change

    -78.87%
    NMRA price is down -78.87% since January 1st

    Price 1-Year Change

    -77.46%
    NMRA price is down -77.46% year-on-year

    Price 3-Year Change

    -
    NMRA price 3-year change is unknown

    Price Range

    Price All-Time High

    $21.00
    NMRA price is currently -89.33% below its historical high of $21.00

    Price 3-Year Low

    $0.61
    NMRA price is currently +266.61% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $374.28M
    NMRA market cap is $374.28 million

    Market Cap 3-Year Change

    -
    NMRA market cap 3-year change is unknown

    Market Cap All-Time High

    $3.14B
    NMRA market cap is currently -88.07% below its historical high of $3.14 billion

    Market Cap Sector Percentile

    58.31%
    NMRA market cap is higher than 58.31% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +3.42%
    NMRA shares outstanding is up +3.42% year-on-year

    Shares Outstanding 3-Year Change

    +9.96%
    NMRA shares outstanding is up +9.96% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.35
    NMRA beta is 1.35

    200-day SMA

    $1.46
    NMRA price is currently +53.41% above its 200-day simple moving average

    50-day SMA

    $2.22
    NMRA price is currently +0.98% above its 50-day simple moving average

    14-Day RSI

    43.86
    NMRA 14-day relative strength index is 43.86

    Volume

    0.16
    NMRA 30-day relative volume is 0.16

    ATR

    $0.22
    NMRA average true range is $0.22

    10-day Historical Volatility

    61.48%
    NMRA 10-day historical volatility is 61.48%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    NMRA annual revenue is $0.00

    Revenue Analysts Estimate

    -
    NMRA annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    0%
    NMRA annual revenue has remained unchanged year-on-year

    Revenue Sector Percentile

    28.31%
    NMRA annual revenue is higher than 28.31% of companies in Healthcare sector

    EPS

    EPS

    -$1.53
    NMRA annual earnings per share is -$1.53

    EPS Analysts Estimate

    -$1.43
    NMRA annual earnings per share is currently -6.93% lower than the consensus analysts' forecast

    EPS 1-Year Change

    -2.98%
    NMRA annual earnings per share is down -2.98% year-on-year

    EPS Sector Percentile

    45.22%
    NMRA annual earnings per share is higher than 45.22% of companies in Healthcare sector

    Profit

    Gross Profit

    -$631.00K
    NMRA annual gross profit is -$631.00 thousand

    Gross Margin

    -
    NMRA annual gross profit margin value is unknown

    Operating Profit

    -$263.46M
    NMRA annual operating income is -$263.46 million

    Operating Margin

    -
    NMRA annual operating profit margin value is unknown

    Net Income

    -$243.79M
    NMRA annual net profit is -$243.79 million

    Net Margin

    -
    NMRA annual net profit margin value is unknown

    Expenses

    Total Expenses

    $243.79M
    NMRA annual total expenses is $243.79 million

    Operating Expenses

    $262.83M
    NMRA annual total operating expenses is $262.83 million

    Cost Of Goods Sold

    $631.00K
    NMRA annual cost of goods sold is $631.00 thousand

    Selling, General & Administrative Expenses

    $62.54M
    NMRA annual SG&A is $62.54 million

    Depreciation & Amortization

    $631.00K
    NMRA annual D&A is $631.00 thousand

    Interest Expense

    $0.00
    NMRA annual interest expense is $0.00

    Income Tax

    $178.00K
    NMRA annual income tax is $178.00 thousand

    EBIT & EBITDA

    EBIT

    -$263.46M
    NMRA annual earnings before interest & taxes is -$263.46 million

    EBITDA

    -$262.83M
    NMRA annual EBITDA is -$262.83 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $316.97M
    NMRA annual total assets is $316.97 million

    Non Current Assets

    $2.92M
    NMRA annual long term assets is $2.92 million

    Current Assets

    $314.06M
    NMRA annual total current assets is $314.06 million

    Cash and Cash Equivalents

    $142.15M
    NMRA annual cash & cash equivalents is $142.15 million

    Accounts Receivable

    -
    NMRA annual accounts receivable value is unknown

    Inventory

    $0.00
    NMRA annual inventory is $0.00

    Liabilities

    Total Liabilities

    $29.91M
    NMRA annual total liabilities is $29.91 million

    Long Term Liabilities

    $22.00K
    NMRA annual total long term liabilities is $22.00 thousand

    Current Liabilities

    $29.89M
    NMRA annual current liabilities is $29.89 million

    Accounts Payable

    $3.31M
    NMRA annual accounts payable is $3.31 million

    Debt

    Total Debt

    $1.85M
    NMRA annual total debt is $1.85 million

    Total Debt 1-Year Change

    -64.58%
    NMRA annual total debt is down -64.58% year-on-year

    Long Term Debt

    $0.00
    NMRA annual long term debt is $0.00

    Short Term Debt

    $1.85M
    NMRA annual short term debt is $1.85 million

    Equity & Capital

    Shareholders Equity

    $287.06M
    NMRA annual stockholders equity is $287.06 million

    Book Value

    $287.06M
    NMRA annual book value is $287.06 million

    Retained Earnings

    -$947.22M
    NMRA annual retained earnings is -$947.22 million

    Working Capital

    $284.17M
    NMRA annual working capital is $284.17 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$182.94M
    NMRA annual cash from operations is -$182.94 million

    Cash From Operations 1-Year Change

    -12.04%
    NMRA annual cash from operations is down -12.04% year-on-year

    Cash From Investing

    -$70.56M
    NMRA annual cash from investing is -$70.56 million

    Cash From Investing 1-Year Change

    -209.58%
    NMRA annual cash from investing is down -209.58% year-on-year

    Cash From Financing

    $21.60M
    NMRA annual cash from financing is $21.60 million

    Cash From Financing 1-Year Change

    -90.69%
    NMRA annual cash from financing is down -90.69% year-on-year

    CAPEX

    CAPEX

    $0.00
    NMRA annual capital expenditures is $0.00

    CAPEX 1-Year Change

    -100%
    NMRA annual capital expenditures is down -100% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$182.94M
    NMRA annual free cash flow is -$182.94 million

    Free Cash Flow 1-Year Change

    -8.9%
    NMRA annual free cash flow is down -8.9% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    NMRA annual gross profit margin value is unknown

    Operating Margin

    -
    NMRA annual operating profit margin value is unknown

    Net Margin

    -
    NMRA annual net profit margin value is unknown

    ROA & ROE

    ROA

    -59.96%
    NMRA annual return on assets is -59.96%

    ROE

    -64.48%
    NMRA annual return on equity is -64.48%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    NMRA price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    NMRA price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    2.83
    NMRA price to book ratio is 2.83

    PB Ratio Sector Percentile

    59.32%
    NMRA price to book ratio is higher than 59.32% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    NMRA price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    NMRA price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $222.84M
    NMRA enterprise value is $222.84 million

    Enterprise Value Sector Percentile

    53.86%
    NMRA enterprise value is higher than 53.86% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.93
    NMRA EV/EBITDA is -0.93

    EV/EBITDA Sector Percentile

    48.61%
    NMRA EV/EBITDA is higher than 48.61% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    10.51
    NMRA annual current ratio is 10.51

    Quick Ratio

    10.51
    NMRA annual quick ratio is 10.51

    Leverage

    Debt To Equity

    0.01
    NMRA annual debt to equity ratio is 0.01

    Interest Coverage Ratio

    -
    NMRA annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    NMRA piotroski f-score value is unknown

    Altman Z-Score

    1.66
    NMRA altman z-score is 1.66

    Analyst ratings

    Recent major analysts updates

    Nov 17, 25 Stifel
    Hold
    Oct 28, 25 Needham
    Buy
    Oct 27, 25 Guggenheim
    Buy
    Sep 16, 25 JP Morgan
    Underweight
    Jul 16, 25 Mizuho
    Outperform
    May 13, 25 Needham
    Buy
    Apr 10, 25 Needham
    Buy
    Apr 2, 25 B of A Securities
    Underperform
    Mar 10, 25 Guggenheim
    Neutral
    Mar 7, 25 Stifel
    Hold

    Institutional Ownership

    Screeners with NMRA included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Neumora Therapeutics, Inc.?
    • Does Neumora Therapeutics, Inc. pay dividends?
    • What sector is Neumora Therapeutics, Inc. in?
    • What industry is Neumora Therapeutics, Inc. in?
    • What country is Neumora Therapeutics, Inc. based in?
    • When did Neumora Therapeutics, Inc. go public?
    • Is Neumora Therapeutics, Inc. in the S&P 500?
    • Is Neumora Therapeutics, Inc. in the NASDAQ 100?
    • Is Neumora Therapeutics, Inc. in the Dow Jones?
    • When was Neumora Therapeutics, Inc.'s last earnings report?
    • When does Neumora Therapeutics, Inc. report earnings?

    What is the ticker symbol for Neumora Therapeutics, Inc.?

    The ticker symbol for Neumora Therapeutics, Inc. is NASDAQ:NMRA

    Does Neumora Therapeutics, Inc. pay dividends?

    No, Neumora Therapeutics, Inc. does not pay dividends

    What sector is Neumora Therapeutics, Inc. in?

    Neumora Therapeutics, Inc. is in the Healthcare sector

    What industry is Neumora Therapeutics, Inc. in?

    Neumora Therapeutics, Inc. is in the Biotechnology industry

    What country is Neumora Therapeutics, Inc. based in?

    Neumora Therapeutics, Inc. is headquartered in United States

    When did Neumora Therapeutics, Inc. go public?

    Neumora Therapeutics, Inc.'s initial public offering (IPO) was on September 15, 2023

    Is Neumora Therapeutics, Inc. in the S&P 500?

    No, Neumora Therapeutics, Inc. is not included in the S&P 500 index

    Is Neumora Therapeutics, Inc. in the NASDAQ 100?

    No, Neumora Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Neumora Therapeutics, Inc. in the Dow Jones?

    No, Neumora Therapeutics, Inc. is not included in the Dow Jones index

    When was Neumora Therapeutics, Inc.'s last earnings report?

    Neumora Therapeutics, Inc.'s most recent earnings report was on November 6, 2025

    When does Neumora Therapeutics, Inc. report earnings?

    The next expected earnings date for Neumora Therapeutics, Inc. is March 2, 2026
    On this page